Key terms
About BOLD
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BOLD news
No recent TipRanks articles are available for BOLD
No recent news articles are available for BOLD
No recent press releases are available for BOLD
BOLD Financials
Key terms
Ad Feedback
BOLD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BOLD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range